| 2021 |
Metzger CE, Swallow EA, Stacy AJ, Tippen SP, Hammond MA, Chen NX, Moe SM, Allen MR. Reversing cortical porosity: cortical pore infilling in preclinical models of chronic kidney disease. Bone. February 2021;143:115632. |
5 |
0 |
| 2021 |
Tippen SP, Noonan ML, Ni P, Metzger CE, Swallow EA, Sacks SA, Chen NX, Thompson WR, Prideaux M, Atkins GJ, Moe SM, Allen MR, White KE. Age and sex effects on FGF23-mediated response to mild phosphate challenge. Bone. May 2021;146:115885. |
4 |
2 |
| 2022 |
Swallow EA, Metzger CE, Newman CL, Chen NX, Moe SM, Allen MR. Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease. Bone. April 2022;157:116340. |
2 |
0 |
| 2023 |
Newman CL, Surowiec RK, Swallow EA, Metzger CE, Kim J, Tomaschke AA, Chen NX, Allen MR, Wallace JM, Moe SM, Wu Y-C, Niziolek PJ. Assessing cortical bone porosity with MRI in an animal model of chronic kidney disease. Bone. August 2023;173:116808. |
0 |
0 |
| 2020 |
Vorland CJ, Biruete A, Lachcik PJ, Srinivasan S, Chen NX, Moe SM, Hill Gallant KM. Kidney disease progression does not decrease intestinal phosphorus absorption in a rat model of chronic kidney disease–mineral bone disorder. J Bone Miner Res. February 2020;35(2):333-342. |
0 |
0 |
| 2020 |
Chen NX, Srinivasan S, O'Neill K, Nickolas TL, Wallace JM, Allen MR, Metzger CE, Creecy A, Avin KG, Moe SM. Effect of advanced glycation end‐products (AGE) lowering drug ALT‐711 on biochemical, vascular, and bone parameters in a rat model of CKD‐MBD. J Bone Miner Res. March 2020;35(3):608-617. |
4 |
4 |
| 2022 |
Damrath JG, Moe SM, Wallace JM. Calcimimetics alter periosteal and perilacunar bone matrix composition and material properties in early chronic kidney disease. J Bone Miner Res. July 2022;37(7):1297-1306. |
1 |
1 |
| 2023 |
Avin KG, Dominguez JM II, Chen NX, Hato T, Myslinski JJ, Gao H, Liu Y, McKinley TO, Brown KM, Moe SM, Natoli RM. Single-cell RNAseq provides insight into altered immune cell populations in human fracture nonunions. J Orthop Res. May 2023;41(5):1060-1069. |
0 |
0 |
| 2006 |
Moe S, Drüeke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. June 1, 2006;69(11):1945-1953. |
33 |
30 |
| 2017 |
Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L, Moe SM, Shroff R, Tonelli MA, Toussaint ND, Vervloet MG, Leonard MB. Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) guideline update: what’s changed and why it matters. Kidney Int. July 2017;92(1):26-36. |
19 |
18 |